The Rise of Xenotransplantation: Research Proposal
Alternative Title
Abstract
In modern xenotransplantation research, genetically modified organs and tissues derived from animals that are physiologically comparable to humans have become a preliminary focus for the solutions to ending the organ shortage crisis we see today. The research offered in this document aims to address the historical applications and the overall development progression for xenotransplantation technologies within the United States and what
factors may have hindered this progress. Specifically, this will be accomplished by understanding the most noteworthy monumental breakthroughs for this field, its safety and efficacy, and the current regulatory procedures and limitations. In doing so, a cohesive projection of what the future could hold for the capabilities of xenotransplantation's triumphant breakthroughs within science and medicinal realms can be presented. Ultimately, a final conclusion could be offered in elucidating what has hindered the growth and implementation of xenotransplantation in modern medicine and how the research of such technology continuously strives to revolutionize the world of organ transplantation as we know it.
Primary Research Questions
1. What can xenotransplantation do for the world and what is the primary goal(s) it works to combat?
2. What are the historical applications of xenotransplantation technology and how does this compare to the modern applications and monumental moments?
3. What are the primary reasons that have hindered the progress in development and the largescale implementation of these technologies?
a. Where did it start?
b. Was there a period in history where there is only limited or potentially no progress documented?
c. Is this due to the regulatory procedures or laws of the given area in which the research takes place?
4. How do the concerns over safety and efficacy of xenotransplantation compare between the historical understandings to those of current ethical discussions?
5. What are the limitations, setbacks, and potentially circumstantial hinderings that have ultimately impacted xenotransplantation?
a. Could this have something to do with the lack of clinical trials and accessibility of nonhuman primates?
b. Are there concerns over the potential zoonotic viruses that could present a threat to the human population?
6. What are the current regulatory procedures for the various organizations within the medical, biotechnological, governmental, and scientific communities?
a. Is there tension over regulatory jurisdiction and how potential policy overlap between organizations impacted by xenotransplantation?